Internal memos, lab reports, and company documents disclosed during legal proceedings paint a troubling picture of what major manufacturers knew about talc contamination — and when they knew it.

What Litigation Has Uncovered

Litigation has forced disclosure of thousands of internal documents from major manufacturers. These include internal emails, lab reports, meeting notes, and marketing materials that were never intended for public release. The documents span decades — from the 1960s through to modern times — and have been central to court proceedings worldwide.

The 1960s Tremolite Memo

Lawyers representing Scottish claimants have referenced a memo from the 1960s that shows manufacturers sought advice from various scientists about the safety of tremolite — a type of asbestos — within their products. This documentation suggests the company was aware of potential asbestos contamination over 60 years ago. Despite this knowledge, the company continued to market its talc products as safe for decades, raising serious questions about corporate accountability and consumer protection.

The Lancet Connection

In March 2026, The Lancet retracted a 1977 unsigned commentary that argued against mandatory asbestos testing in cosmetic talc. Investigation revealed the author, Francis J C Roe, was a paid consultant to manufacturers — a financial interest not disclosed at the time of publication. Documents obtained through litigation discovery showed that Roe provided the company with an advance copy of the paper and incorporated their suggestions before submission.

Public health historians David Rosner and Gerald Markowitz uncovered this undisclosed conflict using litigation disclosure materials. Remarkably, this paper was cited for nearly 50 years as scientific evidence supporting talc safety, despite its compromised authorship. The retraction underscores how corporate influence over scientific publication can have profound public health consequences.

Patterns of Corporate Behaviour

A single memo does not determine the outcome of litigation, but patterns of evidence can prove highly significant in court. Judges and juries weigh the cumulative effect of internal documents showing corporate awareness of risk. When documents consistently demonstrate knowledge of hazards, they provide a powerful foundation for arguments of breach of duty and failure to warn consumers.

The pattern of behaviour in talc cases has already influenced regulatory decisions. Johnson & Johnson agreed to pay $700 million to 43 US states to resolve allegations of misleading marketing about product safety. The company's attempted $8 billion bankruptcy settlement was rejected three times by courts, demonstrating judicial skepticism about the adequacy of proposed remedies.

Why Disclosure Matters for UK Claims

UK legal proceedings have their own rules governing disclosure of evidence, but jurisprudence permits the use of findings and materials from other jurisdictions where appropriate. The Scottish group action led by Jones Whyte will involve formal disclosure processes, during which parties exchange relevant documents and evidence.

For claimants, internally disclosed documents can support the critical argument that risks associated with talc and asbestos contamination were known to manufacturers but not adequately communicated to consumers. For the wider public, these disclosures inform important debate about corporate accountability and the responsibility of manufacturers to prioritize product safety and transparency.

Contact Jones Whyte Lawyers for guidance on how disclosed evidence may affect your talc claim. This article is provided for informational purposes and does not constitute legal advice.